We used receptor autoradiography to study the distribution of ionotropic and metabotropic quisqualate (QA) receptors in normal human cerebeUar cortex and cerebellar cortex from 7 cases of olivopontocerebellar atrophy (OPCA). In normal human cerebellar cortex, both types of QA receptors were densest in the molecular layer. Both ionotropic and metabotropic QA receptors were significantly diminished in the molecular layer of OPCA specimens. These results suggest that both ionotropic and metabotropic QA receptors are localized on Purkinje cell dendrites.
The cerebellar cortex is a convenient region in which to study excitatory amino acid (EAA) receptors because cerebellar neuronal circuitry is relatively well understood 12'18. Morphological and neurochemical evidence supports a neurotransmitter function for EAAs in the cerebellar cortex with glutamate as the possible neurotransmitter of mossy and parallel fibers and aspartate as the possible neurotransmitter of climbing fibers 8'11'28'3°. Electrophysiological evidence indicates that the excitatory actions of EAAs are mediated by at least 3 subtypes of ion channel-linked ('ionotropic') receptors named for the agonists which preferentially excite them: N-methyl-D-aspartate, kainate, and quisqualate 5. In addition, a quisqualate preferring 'metabotropic' receptor linked to inositol phospholipid metabolism has been reported recently 25'26 . Receptor binding studies in animals with genetic, toxic, or viral induced depletions of cerebellar cell types and afferents have been used to determine the cellular localization of EAA receptor subtypes in the cerebellar cortex 2,4,17,21. In particular, accumulated evidence suggests that both ionotropic and metabotropic quisqualate receptors are located on Purkinje cell dendrites3,4,13-15,17.
We have previously reported the distribution and cellular localization of quisqualate-displaceable [3H]glutamate binding in human cerebellar cortex using an assay which likely identifies but does not discriminate both the ionotropic and metabotropic quisqualate receptors 1. In order to provide further information regarding the regional and cellular localization of quisqualate receptors in human brain, we undertook an autoradiographic study of ionotropic and metabotropic quisqualate receptors in the cerebeUar cortex of neurologically normal individuals and patients with olivopontocerebellar atrophy (OPCA), a degenerative disorder characterized by degeneration of cerebellar cortical neurons, particularly Purkinje cells 9.
Blocks of cerebellar cortex were obtained at autopsy from 15 individuals and stored at -70 °C. For controls, we used 4 specimens from individuals without neurologic disease, and 4 from individuals with neurologic disease not affecting the cerebellar cortex. There was one case of multiple sclerosis, one case of Friedreich's ataxia, one case of Huntington's disease, and one case of Alzheimer's disease. The mean age at death of controls was 54 years and the mean post-mortem delay was 13.7 h. Specimens from individuals with neurologic disease not affecting the cerebellar cortex were included to control for the effects of chronic neurologic disease and motor disability. As there were no significant differences in receptor density between neurologically normal and abnormal control specimens, results from these two groups were pooled for comparison with results from the OPCA specimens. We studied 7 cases of pathologically verified OPCA. Two cases were sporadic, the remaining 5 from pedigrees with autosomal dominant inheritance. Two of the latter cases were from a well studied pedigree 24. The mean age at death was 44.4 years and the mean post-mortem delay was 4.0 h. In the molecular layer of OPCA cerebellar cortex, mean specific [3H]AMPA binding was significantly reduced to 50% of the control values (P < 0.01) but was not significantly altered in the granule cell layer (Table I , Fig. 1 ). AiQsGB was reduced in the molecular layer of OPCA cerebeUar cortex to 32% of the control values (P < 0.01) and there was a non-significant trend towards reduction in the granule cell layer (Table I, Fig. 1 ). Cresyl violet-stained sections showed a marked loss of Purkinje cells, marked thinning of the molecular layer, and diminution of the granule cell layer.
Although our single point analysis cannot differentiate between a decrease in receptor number or affinity, Tsiotos et The present study represents the first autoradiographic analysis of both ionotropic and metabotropic quisqualate receptors in normal human and OPCA cerebellar cortex. Our findings are concordant with prior experimental animal data 4'17'2°. In particular, binding to metabotropic and ionotropic quisqualate receptors in the nervous mutant mouse, which exhibits a marked loss of Purkinje cells, reveals binding characteristics similar to those obtained in our OPCA cases. Earlier anatomical studies have established that the disappearance of cerebellar Purkinje cells is a consistent feature of OPCA. Although we cannot exclude the possibility that these binding sites are located on climbing fibers or parallel fiber terminals which are also diminished in OPCA, our results, in conjunction with animal experimental data, suggest that in the human cerebellar cortex both ionotropic and metabotropic quisqualate receptors are concentrated on Purkinje cell dendrites. A glutamate neurotoxic hypothesis has been proposed for the pathogenesis of OPCA 22, and both ionotropic and metabotropic quisqualate receptors have been implicated in neurotoxic processes 6"7. While the etiologic significance of our findings is unclear, enrichment of both subtypes of quisqualate receptors on Purkinje cells could render these cells vulnerable to EAA neurotoxicity in OPCA.
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